Effect of Salbutamol on Walking Capacity in Ambulatory ALS Patients

NCT05860244 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Walking Capacity
Amyotrophic Lateral Sclerosis

Interventions

DRUG: Salbutamol
DRUG: Placebo

Sponsor

Assistance Publique - Hôpitaux de Paris